Fol. Biol. 2004, 50, 159-166
https://doi.org/10.14712/fb2004050050159
Repression of the Melanocyte-Specific Promoter of the Microphthalmia-Associated Transcription Factor by the Adenoviral E1A 12S Oncoprotein
References
1. 1994) Functional interactions within adenovirus E1A protein complexes. Oncogene 9, 359-373.
, D., Charbonneau, R., Whalen, S. G., Bayley, S. T., Branton, P. E. (
2. 1994) Melanocytespecific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol. Cell Biol. 14, 7996-8006.
, N. J., Eisen, T., Goding, C. R. (
3. 1998) Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol. Cell Biol. 18, 694-702.
< , C., Busca, R., Abbe, P., Bille, K., Aberdam, E., Ortonne, J. P., Ballotti, R. (https://doi.org/10.1128/MCB.18.2.694>
4. 2000) Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum. Mol. Genet. 9, 1907-1917.
< , N., Pingault, V., Goerich, D. E., Lemort, N., Sock, E., Caignec, C. L., Wegner, M., Goossens, M. (https://doi.org/10.1093/hmg/9.13.1907>
5. 2001) Recruitment of TRRAP required for oncogenic transformation by E1A. Oncogene 20, 8270-8275.
< , L., Shellard, S., Alevizopoulos, K., Amati, B., Land, H. (https://doi.org/10.1038/sj.onc.1205159>
6. 2002) The NH(2)-terminal and conserved region 2 domains of adenovirus E1A mediate two distinct mechanisms of tumor suppression. Cancer Res. 62, 346-350.
, J., Kloosterbooer, F., Xia, W., Hung, M. C. (
7. 2000) Transformation-defective adenovirus 5 E1A mutants exhibit antioncogenic properties in human BLM melanoma cells. Cancer Gene Ther. 7, 1043-1050.
< , A., Esche, H., Swart, G., Seeber, S., Kirch, H. C., Opalka, B. (https://doi.org/10.1038/sj.cgt.7700206>
8. 1989) Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment. J. Cell Biol. 109, 3115-3128.
< , G. P., Moellmann, G., Ghosh, S., Edwards, M., Halaban, R. (https://doi.org/10.1083/jcb.109.6.3115>
9. 2003) MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Am. J. Pathol. 163, 333-343.
< , J., Miller, A. J., Widlund, H. R., Horstmann, M. A., Ramaswamy, S., Fisher, D. E. (https://doi.org/10.1016/S0002-9440(10)63657-7>
10. 2002) Adenovirus-5 E1A: paradox and paradigm. Nat. Rev. Mol. Cell Biol. 3, 441-452.
< , S. M., Mymryk, J. S. (https://doi.org/10.1038/nrm827>
11. 1990) Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells. Oncogene 5, 75-83.
, S. M., Reich, R., Collier, I. E., Genrich, L. T., Martin, G., Goldberg, G. I. (
12. 1996) Identification of a melanocyte-type promoter of the microphthalmia-associated transcription factor gene. Biochem. Biophys. Res. Commun. 219, 702-707.
< , N., Yasumoto, K., Suzuki, H., Takahashi, K., Shibahara, S. (https://doi.org/10.1006/bbrc.1996.0298>
13. 2001) Adenovirus E1A: remodelling the host cell, a life or death experience. Oncogene 20, 7824-7835.
< , P. H., Turnell, A. S. (https://doi.org/10.1038/sj.onc.1204913>
14. 2000) Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev. 14, 1712-1728.
< , C. R. (https://doi.org/10.1101/gad.14.14.1712>
15. 2000) CBP/p300 in cell growth, transformation, and development. Genes Dev. 14, 1553-1577.
< , R. H., Smolik, S. (https://doi.org/10.1101/gad.14.13.1553>
16. 1996) Growth regulatory proteins that repress differentiation markers in melanocytes also downregulate the transcription factor microphthalmia. J. Invest. Dermatol. 106, 1266-1272.
< , R., Bohm, M., Dotto, P., Moellmann, G., Cheng, E., Zhang, Y. (https://doi.org/10.1111/1523-1747.ep12348972>
17. 2000) The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. EMBO J. 19, 1839-1850.
< , A., Vleminckx, K., Stemmler, M. P., van Roy, F., Kemler, R. (https://doi.org/10.1093/emboj/19.8.1839>
18. 2003) A tissue-restricted cAMP transcriptional response: SOX10 modulates alphamelanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes. J. Biol. Chem. 278, 45224-45230.
< , W. E., Price, E. R., Widlund, H. R., Du, J., Davis, I. J., Wegner, M., Fisher, D. E. (https://doi.org/10.1074/jbc.M309036200>
19. 1999) Microphthalmia transcription factor. A sensitive and specific melanocyte marker for melanoma diagnosis. Am. J. Pathol. 155, 731-738.
< , R., Weilbaecher, K. N., McGill, G., Cooley, E., Mihm, M., Fisher, D. E. (https://doi.org/10.1016/S0002-9440(10)65172-3>
20. 2003) The adenovirus E1A oncoprotein recruits the cellular TRRAP/GCN5 histone acetyltransferase complex. Oncogene 22, 2836-2841.
< , S. E., Hearing, P. (https://doi.org/10.1038/sj.onc.1206376>
21. 2000) Direct regulation of the Microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2. J. Biol. Chem. 275, 37978-37983.
< , M., Goodall, J., Verastegui, C., Ballotti, R., Goding, C. R. (https://doi.org/10.1074/jbc.M003816200>
22. 2002) Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109, 707-718.
< , G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y. L., Ramaswamy, S., Avery, W., Ding, H. F., Jordan, S. A., Jackson, I. J., Korsmeyer, S. J., Golub, T. R., Fisher, D. E. (https://doi.org/10.1016/S0092-8674(02)00762-6>
23. 1998) The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94, 363-374.
< , S. B., Van Buskirk, H. A., Dugan, K. A., Copeland, T. D., Cole, M. D. (https://doi.org/10.1016/S0092-8674(00)81479-8>
24. 2004) Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma. Cancer Res. 64, 509-516.
< , A. J., Du, J., Rowan, S., Hershey, C. L., Widlund, H. R., Fisher, D. E. (https://doi.org/10.1158/0008-5472.CAN-03-2440>
25. 1999) Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300. J. Virol. 73, 3574-3581.
< , M. J., Zimmermann, H., Nielsen, S., Bernard, H. U., Kouzarides, T. (https://doi.org/10.1128/JVI.73.5.3574-3581.1999>
26. 1997) Melanocyte development in vivo and in neural crest cell cultures: crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor. Development 124, 2377-2386.
< , K., Nakayama, A., Nguyen, M. T., Hodgkinson, C. A., Pavan, W. J., Arnheiter, H. (https://doi.org/10.1242/dev.124.12.2377>
27. 2000) Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum. Genet. 107, 1-6.
< , S. B., Furumura, M., Dunn, K. J., Arnheiter, H., Pavan, W. J. (https://doi.org/10.1007/s004390000328>
28. 1998) E1A directly binds and regulates the P/CAF acetyltransferase. EMBO J. 17, 4469-4477.
< , J. L., Bannister, A. J., Zegerman, P., Martinez-Balbas, M. A., Kouzarides, T. (https://doi.org/10.1093/emboj/17.15.4469>
29. 2002) Melanocyte-specific microphthalmia-associated transcription factor isoform activates its own gene promoter through physical interaction with lymphoid-enhancing factor 1. J. Biol. Chem. 277, 28787-28794.
< , H., Yasumoto, K., Takeda, K., Takahashi, K., Fukuzaki, A., Orikasa, S., Shibahara, S. (https://doi.org/10.1074/jbc.M203719200>
30. 2001) Microphthalmia-associated transcription factor (MITF): multiplicity in structure, function, and regulation. J. Investig. Dermatol. Symp. Proc. 6, 99-104.
< , S., Takeda, K., Yasumoto, K., Udono, T., Watanabe, K., Saito, H., Takahashi, K. (https://doi.org/10.1046/j.0022-202x.2001.00010.x>
31. 2000) Induction of melanocyte-specific microphthalmiaassociated transcription factor by Wnt-3a. J. Biol. Chem. 275, 14013-14016.
< , K., Yasumoto, K., Takada, R., Takada, S., Watanabe, K., Udono, T., Saito, H., Takahashi, K., Shibahara, S. (https://doi.org/10.1074/jbc.C000113200>
32. 2000) The transcriptional coactivator CBP interacts with beta-catenin to activate gene expression. J. Cell Biol. 149, 249-254.
< , K. I., Moon, R. T. (https://doi.org/10.1083/jcb.149.2.249>
33. 2000) Structural organization of the human microphthalmia-associated transcription factor gene containing four alternative promoters. Biochim. Biophys. Acta 1491, 205-219.
< , T., Yasumoto, K., Takeda, K., Amae, S., Watanabe, K., Saito, H., Fuse, N., Tachibana, M., Takahashi, K., Tamai, M., Shibahara, S. (https://doi.org/10.1016/S0167-4781(00)00051-8>
34. 2001) Transcriptional repression of the microphthalmia gene in melanoma cells correlates with the unresponsiveness of target genes to ectopic microphthalmia-associated transcription factor. J. Invest. Dermatol. 117, 1505-1511.
< , J., Novotna, H., Ghanem, G. (https://doi.org/10.1046/j.0022-202x.2001.01563.x>
35. 2000) Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10. J. Biol. Chem. 275, 30757-30760.
< , C., Bille, K., Ortonne, J. P., Ballotti, R. (https://doi.org/10.1074/jbc.C000445200>
36. 2002) Suppression of tissue factor expression, cofactor activity, and metastatic potential of murine melanoma cells by the N-terminal domain of adenovirus E1A 12S protein. J. Cell Biochem. 85, 54-71.
< , C., Rand, A., Liu, S. L., Wilson, T. J., Pittelkow, M. R., Getz, M. J., Kelm, R. J., Jr. (https://doi.org/10.1002/jcb.10099>
37. 1993) Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J. Virol. 67, 476-488.
< , H. G., Rikitake, Y., Carter, M. C., Yaciuk, P., Abraham, S. E., Zerler, B., Moran, E. (https://doi.org/10.1128/jvi.67.1.476-488.1993>
38. 1998) Epistatic relationship between Waardenburg syndrome genes MITF and PAX3. Nat. Genet. 18, 283-286.
< , A., Takeda, K., Ploplis, B., Tachibana, M. (https://doi.org/10.1038/ng0398-283>
39. 2002) Betacatenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor. J. Cell Biol. 158, 1079-1087.
< , H. R., Horstmann, M. A., Price, E. R., Cui, J., Lessnick, S. L., Wu, M., He, X., Fisher, D. E. (https://doi.org/10.1083/jcb.200202049>
40. 2003) Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene 22, 3035-3041.
< , H. R., Fisher, D. E. (https://doi.org/10.1038/sj.onc.1206443>
41. 1991) Repressed expression of the HER-2/c-erbB-2 proto-oncogene by the adenovirus E1a gene products. Oncogene 6, 343-345.
, D. H., Chang, L. S., Hung, M. C. (
42. 2002) Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling. EMBO J. 21, 2703-2714.
< , K., Takeda, K., Saito, H., Watanabe, K., Takahashi, K., Shibahara, S. (https://doi.org/10.1093/emboj/21.11.2703>
43. 1995) The Microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription. Oncogene 10, 123-134.
, U., Keenan, E., Lowings, P., Vachtenheim, J., Currie, G., Goding, C. R. (